Patent · US Active

Primer middle sequence interference PCR technology

US10036062B2 · kind B2 · utility

0Cited by
7References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2013
Grant dateJul 31, 2018
Priority date
Expiry dateNov 28, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6848
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided is a primer middle sequence interference PCR method, and the method uses one segment of a non-complemented or same-sequence base of the middle sequence of primers to perform antisense interference inside and outside the primer molecules, so as to competitively destroy the polymerization among the primers to selectively inhibit amplification of the primer dimer (PD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.